Yahoo
NasdaqCM - Delayed Quote USD

Precipio, Inc. (PRPO)

19.35 +0.67 (+3.59%)
At close: 4:00:00 PM EDT
Chart Range Bar
Loading chart for PRPO
  • Previous Close 18.68
  • Open 19.00
  • Bid 16.37 x 100
  • Ask 22.99 x 100
  • Day's Range 19.00 - 19.99
  • 52 Week Range 18.50 - 33.63
  • Volume 10,928
  • Avg. Volume 107,664
  • Market Cap (intraday) 34.64M
  • Beta (5Y Monthly) 1.30
  • PE Ratio (TTM) --
  • EPS (TTM) -0.64
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Motley Fool Rating Bearish

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

www.precipiodx.com

61

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 10/29/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PRPO
15.80%
S&P 500 (^GSPC)
12.78%

1-Year Return

PRPO
6.32%
S&P 500 (^GSPC)
12.04%

3-Year Return

PRPO
154.27%
S&P 500 (^GSPC)
87.51%

5-Year Return

PRPO
59.00%
S&P 500 (^GSPC)
67.64%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY23
Revenue 4.52M
Earnings -1.46M
Profit Margin -32.20%

Q4

FY22

Q1

FY23

Q2

FY23

Q3

FY23

-2M
0
2M
4M
-100.0%
-80.0%
-60.0%
-40.0%

Statistics

View More

Valuation Measures

Annual
As of 10/27/2026
  • Market Cap

    34.01M

  • Enterprise Value

    34.53M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (current)

    --

  • Price/Sales (ttm)

    1.22

  • Price/Book (mrq)

    2.31

  • Enterprise Value/Revenue

    1.27

  • Enterprise Value/EBITDA

    51.30

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -4.47%

  • Return on Assets (ttm)

    -4.81%

  • Return on Equity (ttm)

    -8.98%

  • Revenue (ttm)

    27.2M

  • Net Income Avi to Common (ttm)

    -1.22M

  • Diluted EPS (ttm)

    -0.64

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.08M

  • Total Debt/Equity (mrq)

    24.31%

  • Levered Free Cash Flow (ttm)

    1.35M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

19.35 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: